Market Access Sentinel for Central and Eastern Europe and beyond (MAS CEE)
Central and Eastern Europe (CEE) is a region of 380 million people spanning over twenty countries. Our experience working with HTA in the CEE region has shown that the region holds great potential for MA ready to be uncovered.
Due to a strong competitive environment and existing legal restrictions in local and international markets, activities related to reimbursement require excellent knowledge of all risks and opportunities occurring in the selected market(s). Such knowledge is attained by gathering relevant information from various sources. However, as MA information in the CEE region is supplied in foreign languages, it may be difficult to find and access. In response, INAR created the Market Access Sentinel (MAS) CEE service to allow users quick and easy access to information from multiple sources all in one place, providing the most important and up-to-date MA related information across the CEE region and beyond.
Find out more about MAS
FREE 30-day subscription
To check the possibilities of MAS CEE, take advantage of the FREE 30-day subscription. Simply fill out the form below!
To find out more contact us directly via phone +48 669 774 776/ 669 322 632 or e-mail: MASentinel@inar.pl
Quick and Easy Access to MA News
MAS is a daily service that delivers the most up-to-date MA related news, hand-picked by experts in reimbursement. The service is available in the following formats:
- Daily electronic Newsletter delivered daily to user’s e-mail;
- Online news portal (MASentinel.com) that includes an advanced search engine and other features to enable quick tracking;
- e.g. Tracking marketing authorisation history of a specific product in different countries, reimbursement recommendations and decisions worldwide.
Local Experts and the Internet
MAS is not a computer-generated newsletter, but instead combines the assistance of local MA experts and the Internet. The most significant aspect of MAS is our collaboration with experts, who daily assess and prepare relevant news. This system ensures that users receive MA related information of the highest quality and importance.
More than 600 international news sources are being constantly monitored by experts.
News for MAS is collected from more than 600 international sources and from a network of CEE experts. News sources may include websites of public authorities, regulatory and HTA agencies, as well as popular pharmaceutical websites and news portals. Some agencies that are monitored by our experts include NICE, SMC PBAC, HAS, PTAC, NCPE, IQWiG, CADTH, SBU, ICER, AHRQ KCE, AWMSG, AQuAS, Prescrire as well as local HTA Agencies in CEE countries.
The MAS portal, accessed by users at www.masentinel.com, displays news on new reimbursement recommendations, legal changes, marketing authorisations, drug safety records, clinical trial milestones and important MA-related events. The portal allows users to track similar topics back in time and to tag important information for customised news results (e.g. user may select to view all information from recommendations of selected HTA agencies or information about particular health technologies). The personalised newsletter offers daily delivery to a user’s e-mail inbox, ensuring that important and relevant information is never missed.